[The course of scleroderma following treatment with carnitin].
D000328:Adult; D002331:Carnitine / Q000627:therapeutic use*; D002648:Child; D005069:Evaluation Studies as Topic; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008875:Middle Aged; D012594:Scleroderma, Localized / Q000188:drug therapy*; D012595:Scleroderma, Systemic / Q000188:drug therapy*
D002331:Carnitine
Der Krankheitsverlauf der Sklerodermie nach Behandlung mit Karnitin